Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 520.61 Million CNY | 199.15% |
| 2022 | 174.03 Million CNY | 118.93% |
| 2021 | 79.49 Million CNY | 271.06% |
| 2020 | -46.47 Million CNY | -111.26% |
| 2019 | 412.84 Million CNY | 9.11% |
| 2018 | 378.37 Million CNY | -3.12% |
| 2017 | 390.54 Million CNY | 0.09% |
| 2016 | 390.18 Million CNY | 10.28% |
| 2015 | 353.8 Million CNY | 13.69% |
| 2014 | 311.21 Million CNY | 82.32% |
| 2013 | 170.69 Million CNY | -32.02% |
| 2012 | 251.09 Million CNY | 16.66% |
| 2011 | 215.23 Million CNY | 83.61% |
| 2010 | 117.22 Million CNY | 31.91% |
| 2009 | 88.86 Million CNY | 163.88% |
| 2008 | -139.12 Million CNY | -47.68% |
| 2007 | -94.2 Million CNY | -162.64% |
| 2006 | 150.39 Million CNY | -37.83% |
| 2005 | 241.88 Million CNY | -5.41% |
| 2004 | 255.71 Million CNY | 32.41% |
| 2003 | 193.11 Million CNY | 116.0% |
| 2002 | 89.4 Million CNY | -5.21% |
| 2001 | 94.31 Million CNY | 322.43% |
| 2000 | 22.32 Million CNY | -49.46% |
| 1999 | 44.18 Million CNY | -64.84% |
| 1998 | 125.65 Million CNY | 29.48% |
| 1997 | 97.04 Million CNY | 21.1% |
| 1996 | 80.14 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 593.63 Million CNY | 14.03% |
| 2024 Q2 | 676.55 Million CNY | 13.97% |
| 2024 Q3 | 366.58 Million CNY | -48.13% |
| 2023 Q2 | -3.56 Million CNY | -101.32% |
| 2023 Q3 | 418.21 Million CNY | 11825.27% |
| 2023 Q1 | 269.3 Million CNY | 54.75% |
| 2023 FY | 520.61 Million CNY | 199.15% |
| 2023 Q4 | 520.61 Million CNY | 24.49% |
| 2022 FY | 174.03 Million CNY | 118.93% |
| 2022 Q4 | 174.03 Million CNY | 15.81% |
| 2022 Q3 | 150.26 Million CNY | -5.44% |
| 2022 Q2 | 158.91 Million CNY | 113.27% |
| 2022 Q1 | 74.51 Million CNY | -6.27% |
| 2021 Q3 | 60.46 Million CNY | 106.35% |
| 2021 Q4 | 79.49 Million CNY | 31.48% |
| 2021 Q1 | -46.22 Million CNY | 0.52% |
| 2021 Q2 | 29.3 Million CNY | 163.38% |
| 2021 FY | 79.49 Million CNY | 271.06% |
| 2020 Q2 | 23.32 Million CNY | -54.97% |
| 2020 Q1 | 51.8 Million CNY | -87.45% |
| 2020 Q3 | 105.49 Million CNY | 352.2% |
| 2020 Q4 | -46.47 Million CNY | -144.05% |
| 2020 FY | -46.47 Million CNY | -111.26% |
| 2019 Q2 | 447.6 Million CNY | 10.13% |
| 2019 Q1 | 406.43 Million CNY | 7.42% |
| 2019 FY | 412.84 Million CNY | 9.11% |
| 2019 Q3 | 381.83 Million CNY | -14.69% |
| 2019 Q4 | 412.84 Million CNY | 8.12% |
| 2018 Q1 | 401.73 Million CNY | 2.87% |
| 2018 FY | 378.37 Million CNY | -3.12% |
| 2018 Q4 | 378.37 Million CNY | 6.22% |
| 2018 Q3 | 356.22 Million CNY | -12.61% |
| 2018 Q2 | 407.62 Million CNY | 1.47% |
| 2017 Q2 | 459.67 Million CNY | 11.51% |
| 2017 FY | 390.54 Million CNY | 0.09% |
| 2017 Q1 | 412.24 Million CNY | 5.65% |
| 2017 Q3 | 444.07 Million CNY | -3.39% |
| 2017 Q4 | 390.54 Million CNY | -12.05% |
| 2016 Q2 | 348.58 Million CNY | 11.03% |
| 2016 FY | 390.18 Million CNY | 10.28% |
| 2016 Q4 | 390.18 Million CNY | 0.8% |
| 2016 Q3 | 387.1 Million CNY | 11.05% |
| 2016 Q1 | 313.95 Million CNY | -11.26% |
| 2015 Q2 | 232.24 Million CNY | -46.26% |
| 2015 FY | 353.8 Million CNY | 13.69% |
| 2015 Q4 | 353.8 Million CNY | 42.71% |
| 2015 Q3 | 247.91 Million CNY | 6.75% |
| 2015 Q1 | 432.16 Million CNY | 38.86% |
| 2014 Q2 | 106.06 Million CNY | 86.73% |
| 2014 Q4 | 311.21 Million CNY | 290.37% |
| 2014 FY | 311.21 Million CNY | 82.32% |
| 2014 Q1 | 56.8 Million CNY | -66.72% |
| 2014 Q3 | 79.72 Million CNY | -24.84% |
| 2013 FY | 170.69 Million CNY | -32.02% |
| 2013 Q3 | 247.88 Million CNY | -4.59% |
| 2013 Q2 | 259.82 Million CNY | 22.58% |
| 2013 Q1 | 211.96 Million CNY | -15.58% |
| 2013 Q4 | 170.69 Million CNY | -31.14% |
| 2012 Q4 | 251.09 Million CNY | -10.11% |
| 2012 Q3 | 279.34 Million CNY | -2.1% |
| 2012 Q1 | 239.9 Million CNY | 11.46% |
| 2012 FY | 251.09 Million CNY | 16.66% |
| 2012 Q2 | 285.32 Million CNY | 18.93% |
| 2011 FY | 215.23 Million CNY | 83.61% |
| 2011 Q2 | 131.77 Million CNY | 1.27% |
| 2011 Q4 | 215.23 Million CNY | 23.22% |
| 2011 Q1 | 130.12 Million CNY | 11.01% |
| 2011 Q3 | 174.67 Million CNY | 32.56% |
| 2010 Q2 | 118.99 Million CNY | -1.57% |
| 2010 FY | 117.22 Million CNY | 31.91% |
| 2010 Q3 | 113.81 Million CNY | -4.35% |
| 2010 Q1 | 120.89 Million CNY | 36.04% |
| 2010 Q4 | 117.22 Million CNY | 2.99% |
| 2009 Q4 | 88.86 Million CNY | 286.5% |
| 2009 Q1 | -101.41 Million CNY | 27.1% |
| 2009 Q2 | -26.27 Million CNY | 74.09% |
| 2009 Q3 | 22.99 Million CNY | 187.51% |
| 2009 FY | 88.86 Million CNY | 163.88% |
| 2008 Q3 | -125.22 Million CNY | 12.79% |
| 2008 Q4 | -139.12 Million CNY | -11.09% |
| 2008 Q1 | -199.97 Million CNY | -112.28% |
| 2008 FY | -139.12 Million CNY | -47.68% |
| 2008 Q2 | -143.59 Million CNY | 28.19% |
| 2007 Q3 | -6.83 Million CNY | -107.26% |
| 2007 Q4 | -94.2 Million CNY | -1277.58% |
| 2007 FY | -94.2 Million CNY | -162.64% |
| 2007 Q1 | 149.73 Million CNY | -0.44% |
| 2007 Q2 | 94.15 Million CNY | -37.12% |
| 2006 Q4 | 150.39 Million CNY | -12.78% |
| 2006 Q2 | 183.33 Million CNY | -15.58% |
| 2006 Q1 | 217.16 Million CNY | -10.22% |
| 2006 FY | 150.39 Million CNY | -37.83% |
| 2006 Q3 | 172.43 Million CNY | -5.94% |
| 2005 Q4 | 241.88 Million CNY | -1.75% |
| 2005 Q3 | 246.2 Million CNY | -8.34% |
| 2005 Q2 | 268.59 Million CNY | 2.39% |
| 2005 Q1 | 262.32 Million CNY | 2.59% |
| 2005 FY | 241.88 Million CNY | -5.41% |
| 2004 Q2 | 247.33 Million CNY | 7.72% |
| 2004 FY | 255.71 Million CNY | 32.41% |
| 2004 Q1 | 229.6 Million CNY | 18.89% |
| 2004 Q3 | 249.58 Million CNY | 0.91% |
| 2004 Q4 | 255.71 Million CNY | 2.46% |
| 2003 Q2 | 164.7 Million CNY | 3.76% |
| 2003 Q3 | 175.09 Million CNY | 6.31% |
| 2003 Q1 | 158.72 Million CNY | 77.54% |
| 2003 FY | 193.11 Million CNY | 116.0% |
| 2003 Q4 | 193.11 Million CNY | 10.29% |
| 2002 FY | 89.4 Million CNY | -5.21% |
| 2002 Q2 | 88.81 Million CNY | 197.33% |
| 2002 Q1 | -91.26 Million CNY | -196.76% |
| 2002 Q3 | 28.43 Million CNY | -67.99% |
| 2002 Q4 | 89.4 Million CNY | 214.43% |
| 2001 Q2 | 42.86 Million CNY | 0.0% |
| 2001 Q4 | 94.31 Million CNY | 0.0% |
| 2001 FY | 94.31 Million CNY | 322.43% |
| 2000 Q2 | 32.9 Million CNY | 0.0% |
| 2000 FY | 22.32 Million CNY | -49.46% |
| 2000 Q4 | 22.32 Million CNY | 0.0% |
| 1999 Q4 | 44.18 Million CNY | 0.0% |
| 1999 Q2 | 129.76 Million CNY | 0.0% |
| 1999 FY | 44.18 Million CNY | -64.84% |
| 1998 FY | 125.65 Million CNY | 29.48% |
| 1997 FY | 97.04 Million CNY | 21.1% |
| 1996 FY | 80.14 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 935.92 Million CNY | 44.374% |
| Zhejiang Zhenyuan Share Co., Ltd. | -320.75 Million CNY | 262.307% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 580.71 Million CNY | 10.349% |
| Yifan Pharmaceutical Co., Ltd. | 1.29 Billion CNY | 59.854% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | -129.14 Million CNY | 503.137% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.88 Billion CNY | 81.926% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -562.43 Million CNY | 192.564% |
| Boai NKY Medical Holdings Ltd. | -230.36 Million CNY | 325.994% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | -1.1 Billion CNY | 146.947% |